Javascript must be enabled to continue!
SNORA42 Promote Oesophageal Squamous Cell Carcinoma Development Through Interacting With Dhx9
View through CrossRef
Abstract
Background:Oesophageal squamous cell carcinoma (ESCC) is a high malignant cancer, which is the most common subtype of oesophageal cancer. Small nucleolar RNAs (snoRNAs) are a group of novel non-coding RNAs that have been found play a key role in various cancers. Methods:The expression of SNORA42 in ESCC samples and cell lines was measured by using real-time PCR and a series of in vitro and in vivo assays were performed to determine the function of SNORA42 in ESCC. Furthermore, RNA pull-down assay combined with Mass Spectrometry was applied to identify the protein that is associated with SNORA42. Silencing SNORA42 in ESCC cell followed by Next-Generation mRNA Sequencing was used to investigate the signaling pathway regulated by SNORA42.Results: We identified H/ACA box snoRNA42 (SNORA42) wasupregulated in ESCC and had the potential to be applied as a prognostic marker. Specifically, overexpression of SNORA42 promotedESCCprogressionin vitro and in vivo, whereas knockdown of SNORA42 had opposite effects. We identified SNORA42 interacted with DHX9, which was up-regulated in ESCC and had a positive correlation with the expression of SNORA42. Furthermore, the promotion of SNORA42 on ESCC phenotypes can be reversed by knockdown of DHX9. Mechanically, SNORA42 promoted DHX9 expression by attenuating DHX9 transports into cytoplasm, to protect DHX9 from being ubiquitinated and degraded. From KEGG analysis of Next-Generation Sequencing, the NF-κB pathway was one of the most regulated pathways by SNORA42. SNORA42 enhanced phosphorylation of p65 and this effect could be reversed by NF-κB inhibitor, BAY11-7082. Moreover, SNORA42 activated NF-κB signaling through promotingthe transcriptional co-activator DHX9 interacted with p-p65, inducingNF-κB downstream genes expression. Conclusions:These findings suggest that SNORA42 is up-regulated in ESCC and promotes ESCC developments,partly via interacting with DHX9 and triggering SNORA42/DHX9/p65 axis.
Springer Science and Business Media LLC
Title: SNORA42 Promote Oesophageal Squamous Cell Carcinoma Development Through Interacting With Dhx9
Description:
Abstract
Background:Oesophageal squamous cell carcinoma (ESCC) is a high malignant cancer, which is the most common subtype of oesophageal cancer.
Small nucleolar RNAs (snoRNAs) are a group of novel non-coding RNAs that have been found play a key role in various cancers.
Methods:The expression of SNORA42 in ESCC samples and cell lines was measured by using real-time PCR and a series of in vitro and in vivo assays were performed to determine the function of SNORA42 in ESCC.
Furthermore, RNA pull-down assay combined with Mass Spectrometry was applied to identify the protein that is associated with SNORA42.
Silencing SNORA42 in ESCC cell followed by Next-Generation mRNA Sequencing was used to investigate the signaling pathway regulated by SNORA42.
Results: We identified H/ACA box snoRNA42 (SNORA42) wasupregulated in ESCC and had the potential to be applied as a prognostic marker.
Specifically, overexpression of SNORA42 promotedESCCprogressionin vitro and in vivo, whereas knockdown of SNORA42 had opposite effects.
We identified SNORA42 interacted with DHX9, which was up-regulated in ESCC and had a positive correlation with the expression of SNORA42.
Furthermore, the promotion of SNORA42 on ESCC phenotypes can be reversed by knockdown of DHX9.
Mechanically, SNORA42 promoted DHX9 expression by attenuating DHX9 transports into cytoplasm, to protect DHX9 from being ubiquitinated and degraded.
From KEGG analysis of Next-Generation Sequencing, the NF-κB pathway was one of the most regulated pathways by SNORA42.
SNORA42 enhanced phosphorylation of p65 and this effect could be reversed by NF-κB inhibitor, BAY11-7082.
Moreover, SNORA42 activated NF-κB signaling through promotingthe transcriptional co-activator DHX9 interacted with p-p65, inducingNF-κB downstream genes expression.
Conclusions:These findings suggest that SNORA42 is up-regulated in ESCC and promotes ESCC developments,partly via interacting with DHX9 and triggering SNORA42/DHX9/p65 axis.
Related Results
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis
Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis
Background:The antiapoptotic and epithelial–mesenchymal transition activities of Twist have been implicated in the neoplastic transformation and the development of metastasis, resp...
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Abstract
Introduction
Microwave ablation (MWA) has emerged as a minimally invasive treatment for patients with inoperable non-small cell lung cancer (NSCLC). However, whether it i...
Oral Papillary Squamous Cell Carcinoma and Oral Squamous Cell Carcinoma: A Histopathological and Immunohistochemical Comparative Study
Oral Papillary Squamous Cell Carcinoma and Oral Squamous Cell Carcinoma: A Histopathological and Immunohistochemical Comparative Study
Abstract
Purpose
The aim of the study is to investigate the immunohistochemical expression of both Alpha smooth muscle actin and Transforming Growth...
Carcinoma ex Pleomorphic Adenoma: A Case Series and Literature Review
Carcinoma ex Pleomorphic Adenoma: A Case Series and Literature Review
Abstract
Introduction
Carcinoma ex pleomorphic adenoma (CXPA) is a rare malignant salivary gland tumor that can lead to severe complications and carries a risk of distant metastasi...
Clinical and Paraclinical Characteristics of Endobronchial Pulmonary Squamous Cell Carcinoma—A Brief Review
Clinical and Paraclinical Characteristics of Endobronchial Pulmonary Squamous Cell Carcinoma—A Brief Review
Background: Endobronchial squamous cell carcinoma is one of the most common types of tumors located inside the tracheobronchial tree. Patients often present in advanced stages of t...
P75 CRITICAL APPRAISAL OF THE IMPACT OF OESOPHAGEAL STENTS IN THE MANAGEMENT OF OESOPHAGEAL ANASTOMOTIC LEAKS AND BENIGN OESOPHAGEAL PERFORATIONS: AN UPDATED SYSTEMATIC REVIEW
P75 CRITICAL APPRAISAL OF THE IMPACT OF OESOPHAGEAL STENTS IN THE MANAGEMENT OF OESOPHAGEAL ANASTOMOTIC LEAKS AND BENIGN OESOPHAGEAL PERFORATIONS: AN UPDATED SYSTEMATIC REVIEW
Abstract
Aims
This updated systematic review aimed to assess the safety and effectiveness of oesophageal stents in these two sce...
SQUAMOUS CELL CARCINOMA OF THE SKIN
SQUAMOUS CELL CARCINOMA OF THE SKIN
Introduction: squamous cell carcinoma is steadily increasing year after year, representing a major public health challenge. The mortality rates of dermal squamous cell carcinoma ar...


